NORD Applauds Legislative Efforts to Restore Intent of the Orphan Drug Act

WASHINGTON, May 11, 2022 /PRNewswire/ — The National Organization for Rare Disorders (NORD) applauds efforts of Congressional leaders to protect the Orphan Drug Act (ODA) and ensure proper incentives are in place to continue to foster robust rare disease drug development. Last week,…